Living with Non-alcoholic Steatohepatitis (NASH) EU is a study conducted amongst 275 adults with NASH / NAFLD in France, Germany, Italy, Spain and UK. The report consists of 30-minute quantitative online and qualitative telephone interviews with patients. The report, which is now available for purchase, enables pharmaceutical companies developing products in this disease area to gain a deeper understanding of how patients come to be diagnosed with NASH, how it impacts their day-to-day lives and what their attitudes and perceptions are towards the management of their condition.
NASH is a type of non-alcoholic fatty liver disease (NAFLD) in which inflammation and liver cell damage exists in addition to fat in the liver. It can lead to complications, such as cirrhosis and liver cancer. The prevalence of NAFLD in the general population ranges from 20% to 30% in Europe and will become the leading cause of liver transplantation in the next 10-20 years.
Head of Living with, Mariel Metcalfe commented, “Research Partnership has a deep understanding of liver diseases with over 100 ad hoc studies conducted to date, as well as completion of the Living with NASH US report in 2017. This report provides an in-depth understanding of the physical and emotional journey of those living with NASH or NAFLD from pre-diagnosis to current management”
To discover more, download our new interactive infographic to unlock key insights from various Living With reports to reveal patient behaviours, attitudes and unmet needs at different stages of their chronic disease journey. Download the infographic »
Research Partnership
All the latest news from Research Partnership
